News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare Disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

RF-positive polyarticular JIA looks like adult RA
MDedge Internal Medicine
Serotonin syndrome risk with triptans and antidepressants ‘very low’
MDedge Internal Medicine
‘Right to try’ bill passes House
MDedge Internal Medicine
Think about breast cancer surveillance for transgender patients
MDedge Internal Medicine
FDA approves burosumab to treat X-linked hypophosphatemia
MDedge Internal Medicine
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Internal Medicine
Heart disease in GPA exacts high toll in year 2 and beyond
MDedge Internal Medicine
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Internal Medicine
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Internal Medicine
RFPs Available for the Study of Three Rare Diseases
MDedge Internal Medicine